
About ELEVAI Labs
ELEVAI Labs is a publicly listed company based in California City (United States) founded in 2020 by Jordan Plews, Braeden Lichti, and Tim Sayed. Regenerative aesthetic dermatology products are developed using stem cell exosomes. The company has 18 employees. Its chief executive, as recorded, is Jordan Plews. Its focus areas include Life Sciences, Dermatology, Drugs and Aesthetics. Its legal entity is ELEVAI LABS INC. Its competitors include One Skin Technologies, Fount Bio and Elyse Scientific Cosmetics; 1 of its 3 listed competitors has raised funding.
Company details
ELEVAI Labs was founded in 2020 and is headquartered in California City, United States. Regenerative aesthetic dermatology products are developed by the company, focusing on stem cell exosome technology derived from mesenchymal stem cells. ENFINITY and EMPOWER systems are offered, providing topical skincare and aesthetic solutions within the biotechnology sector. Operations emphasize innovation in dermatological applications for aesthetic purposes.
- Headquarters California City, United States
- Employees 18
- Founders Jordan Plews, Braeden Lichti, Tim Sayed
- Stage Public
- SectorsHealthcare
- Website elevailabs.com
- Social LinkedIn
- Legal Name Elevai Labs Inc
- Annual Revenue$1.71 M (USD)123as on Dec 31, 2023
- Net Profit-$4.3 M (USD)-139as on Dec 31, 2023
- EBITDA-$3.76 M (USD)-110as on Dec 31, 2023
- Employee Count18
People of ELEVAI Labs
3 people are tracked at ELEVAI Labs (3 in leadership); the tracked headcount is 18.
| Name | Role | Group |
|---|---|---|
Jordan Plews | Co-Founder & CEO | Leadership |
Braeden Lichti | Co-Founder & Chairman | Leadership |
Tim Sayed | Co-Founder & CMO | Leadership |
Complete people profiles for ELEVAI Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of ELEVAI Labs
ELEVAI Labs is a publicly listed company on the NASDAQ with ticker symbol ELAB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date21 Nov 2023
- Listed onNASDAQ: ELAB
- Listed entityPMGC Holdings Inc.
- Exchange sectorHealth technology
Competitors of ELEVAI Labs
ELEVAI Labs has 3 listed competitors in our database, 1 of them funded. They include One Skin Technologies, Fount Bio and Elyse Scientific Cosmetics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| oneskin.co | 2016 | San Francisco, United States | $40.9M | Developer of a skin therapy product to treat skin aging | ||
| fountbio.com | 2019 | Cambridge, United States | Glycopolymer-based products for tissue rejuvenation are developed. | |||
| elyseecosmetics.com | 2001 | Cottondale, United States | Skincare products including serums and moisturizers are offered online. |
Detailed competitors of ELEVAI Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Dermatology
3 companies that operate in the same segment as ELEVAI Labs (Dermatology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Elevai Labs
Complete news archive for ELEVAI Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ELEVAI Labs
ELEVAI Labs was founded in 2020.
ELEVAI Labs is headquartered in California City, United States. It is registered at California City, California, United States.
Jordan Plews is the CEO of ELEVAI Labs, as recorded in our data. They have also founded this company.
ELEVAI Labs has 18 employees.
Annual revenue of ELEVAI Labs is $1.71M as on Dec 31, 2023.
ELEVAI Labs was founded in 2020 and is headquartered in California City, United States. Regenerative aesthetic dermatology products are developed by the company, focusing on stem cell exosome technology derived from mesenchymal stem cells. ENFINITY and EMPOWER systems are offered, providing topical skincare and aesthetic solutions within the biotechnology sector. Operations emphasize innovation in dermatological applications for aesthetic purposes.
ELEVAI Labs's top competitors include One Skin Technologies, Fount Bio and Elyse Scientific Cosmetics.
Yes, ELEVAI Labs is publicly traded on NASDAQ under the ticker symbol ELAB.
ELEVAI Labs operates through Elevai Labs Inc.
